Can Comprehensive Geriatric Assessment Predict Tolerance of Radiotherapy for Localized Prostate Cancer in Men Aged 75...

Area of Science:

• Geriatric Oncology
• Radiation Oncology
• Quality of Life Research

Background:

• Radiotherapy for prostate cancer is common in elderly patients.
• Concerns about toxicity and preserving quality of life (QoL) impact treatment access for this demographic.

Purpose of the Study:

• To identify predictors of impaired QoL in men aged 75+ treated with curative radiotherapy for localized prostate cancer.
• To evaluate the impact of radiotherapy with or without androgen deprivation therapy (ADT) on QoL in elderly men.

Main Methods:

• Prospective study of 208 elderly patients (>75 years) undergoing radiotherapy for prostate cancer.
• Comprehensive geriatric assessment (CGA) and QoL questionnaires administered pre-treatment and at 2 and 6 months post-treatment.
• Analysis of tumor characteristics, treatment details, and oncogeriatric parameters as potential QoL predictors.

Main Results:

• At 6 months post-radiotherapy, 75% of patients maintained their QoL.
• No studied parameters (tumor, treatment, or oncogeriatric) predicted reduced QoL.
• Common baseline geriatric impairments (comorbidities, depression, cognitive issues) did not consistently predict decreased QoL.

Conclusions:

• Curative radiotherapy can maintain QoL for a majority of elderly prostate cancer patients.
• Current CGA is not a strong predictor of QoL tolerance following radiotherapy.
• Development of specialized geriatric assessments for QoL post-radiotherapy is needed.